The Safety and Efficacy of ZVS106e in the Treatment of IRDs Caused by Biallelic Mutations in ABCA4

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Stargardt

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Third Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Jinlu Zhang, MD) · zhangjinlu@chinagene.cc · +86-15810570898
Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Jinlu Zhang, MD) · zhangjinlu@chinagene.cc · +86-15810570898

Study leads

qingjiong zhang, M.D
Study Director
PI
lin Lv, M.D
Principal Investigator
PI

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 1 Study of C.001 in Retinal Degeneration

Geographic Atrophy · Stargardt Disease · RPE-mediated Maculopathy

Abroad (travel likely)RecruitingPHASE1

Beverly Hills, United States

A Study of DC6001 Tablet in Healthy Chinese Adult Subjects

Stargardt Disease

Abroad (travel likely)RecruitingPHASE1

Beijing, China

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

Alcohol Use Disorder · Retinal Dystrophies · Age-Related Macular Degeneration

Abroad (travel likely)RecruitingPHASE1

Rochester, United States

An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

Stargardt Disease Type 1 (STGD1)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China